tiprankstipranks
Trending News
More News >
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market

Symbio Pharmaceuticals Limited (4582) Income Statement

Compare
1 Followers

Symbio Pharmaceuticals Limited Income Statement

Last quarter (Q4 2024), Symbio Pharmaceuticals Limited's total revenue was ¥554.54M, a decrease of -52.55% from the same quarter last year. In Q4, Symbio Pharmaceuticals Limited's net income was ¥-988.46M. See Symbio Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 2.45B¥ 5.59B¥ 10.01B¥ 8.25B¥ 2.99B
Gross Profit
¥ 1.87B¥ 4.41B¥ 7.60B¥ 5.80B¥ 866.85M
Operating Expenses
¥ 5.75B¥ 5.22B¥ 5.64B¥ 4.78B¥ 5.37B
Depreciation and Amortization
¥ 96.00M¥ 96.00M¥ 98.09M¥ 93.96M¥ 63.84M
EBITDA
¥ -3.78B¥ -714.00M¥ 2.20B¥ 1.11B¥ -4.44B
Operating Income
¥ -3.88B¥ -811.67M¥ 1.96B¥ 1.02B¥ -4.51B
Other Income/Expenses
¥ 70.01M¥ -383.72M¥ 142.65M¥ -14.67M¥ 419.80M
Pretax Income
¥ -3.81B¥ -1.20B¥ 2.11B¥ 1.00B¥ -4.09B
Net Income
¥ -3.83B¥ -1.96B¥ 1.18B¥ 2.03B¥ -4.09B
Per Share Metrics
Basic EPS
¥ -85.00¥ -49.19¥ 30.20¥ 53.04¥ -124.13
Diluted EPS
¥ -85.00¥ -49.19¥ 29.77¥ 52.32¥ -124.13
Weighted Average Shares Outstanding
45.10M 39.90M 39.05M 38.31M 32.95M
Weighted Average Shares Outstanding (Diluted)
45.10M 39.90M 39.61M 38.84M 32.95M
Currency in JPY

Symbio Pharmaceuticals Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis